---
schema_version: "secwatch.filing_event.v1"
accession: "0001145197-22-000059"
form_type: "8-K"
ticker: "PODD"
cik: "0001145197"
company_name: "INSULET CORP"
filed_at: "2022-11-03T23:59:59+00:00"
generated_at: "2026-06-22T08:03:27.492615+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Insulet Q3 revenue $340.8M (+24% YoY) beat guidance; Omnipod 5 drives 42% US growth

## Summary
- Revenue $340.8M, +23.7% YoY (+28.5% constant currency), above guidance of 17-20% constant currency.
- US Omnipod revenue $238.1M (+42.4% YoY) on record new customer starts; International Omnipod $88.0M (-5.5%, +8.9% CC).
- Adjusted EPS $0.45; GAAP net loss $(0.08)/share includes $36.8M charge for voluntary Omnipod DASH PDM correction.
- Adjusted gross margin 66.1% (excl. PDM charge); GAAP gross margin 55.3%, down 1,320 bps.
- Received CE Mark for Omnipod 5; expanded US indication to age 2; new basal-only pod for type 2 diabetes planned for 510(k).

## SEC filing metadata
- accession: 0001145197-22-000059
- form_type: 8-K
- ticker: PODD
- cik: 0001145197
- company_name: INSULET CORP
- filed_at: 2022-11-03T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1145197/000114519722000059/0001145197-22-000059-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1145197/000114519722000059/podd-20221103.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001145197-22-000059
- JSON: https://secwatch.observer/filing/0001145197-22-000059.json
- Plain text: https://secwatch.observer/filing/0001145197-22-000059.txt

## Key facts
- Earnings Releases
  INSULET CORP reported the three months ended September 30, 2022 results: revenue $340.8 million, net income Net loss of $5.2 million, or $(0.08) per diluted share, EPS $(0.08) per diluted share.
  - Period: the three months ended September 30, 2022
  - Revenue: $340.8 million
  - Net income: Net loss of $5.2 million, or $(0.08) per diluted share
  - EPS: $(0.08) per diluted share
  - Result: reported results
  source text: Omnipod ® brand of products, today announced financial results for the three months ended September 30, 2022. Third Quarter Financial Highlights: • Third quarter 2022 revenue of $340.8 million, up 23.7%, or 28.5% in constant currency 1 , compared to $275.6 million in the prior year, exceeds the guidance range of 17% to 20% in constant currency ◦ Total Omnipod revenue
  evidence_url: https://www.sec.gov/Archives/edgar/data/1145197/000114519722000059/0001145197-22-000059-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.